Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

Why Are Pharmacokinetic Drug-Drug Interactions “Not Seen?

0
Posted

Why Are Pharmacokinetic Drug-Drug Interactions “Not Seen?

0

” First, lets review some general background. Obviously, adverse drug-drug interactions often occur in a complex medical setting; the patient may have more than one illness or an illness that has been refractory to monodrug therapy.1 Hence, the physician must often consider multiple possible explanations for the adverse event, including the underlying illness, the development of a new illness, or a problem with the patients “sensitivity” or “resistance” to the treatment regimen. In addition to these possibilities, the adverse outcome may also be due to an untoward interaction among the drugs the patient is taking. In the case of pharmacodynamic interactions, the effects of one drug on its site(s) of action may amplify or diminish the response of the patient to the effect of a coprescribed drug on its site(s) of action (e.g., a serotonin uptake inhibitor and a monoamine oxidase inhibitor). In the case of a pharmacokinetic interaction, one drug may alter the absorption, distribution, met

0

” First, lets review some general background. Obviously, adverse drug-drug interactions often occur in a complex medical setting; the patient may have more than one illness or an illness that has been refractory to monodrug therapy.1 Hence, the physician must often consider multiple possible explanations for the adverse event, including the underlying illness, the development of a new illness, or a problem with the patients “sensitivity” or “resistance” to the treatment regimen. In addition to these possibilities, the adverse outcome may also be due to an untoward interaction among the drugs the patient is taking. In the case of pharmacodynamic interactions, the effects of one drug on its site(s) of action may amplify or diminish the response of the patient to the effect of a coprescribed drug on its site(s) of action (e.g., a serotonin uptake inhibitor and a monoamine oxidase inhibitor). In the case of a pharmacokinetic interaction, one drug may alter the absorption, distribution, met

Related Questions

What is your question?

*Sadly, we had to bring back ads too. Hopefully more targeted.